Editorial: Novel signaling pathways and therapy in breast cancer

por Katsuta, Eriko, Opyrchal, Mateusz
Publicado 2023

Harnessing tumorous flaws for immune supremacy: is miRNA-155 the weak link in breast cancer progression?

por Sharma, Samantha, Opyrchal, Mateusz, Lu, Xiongbin
Publicado 2022

Understanding and targeting erythroid progenitor cells for effective cancer therapy

por Wang, Qingfei, Poole, Rylee A., Opyrchal, Mateusz
Publicado 2023

Spontaneous Tumor Lysis Syndrome in the Setting of B-Cell Lymphoma

por Opyrchal, Mateusz, Figanbaum, Travis, Ghosh, Amit, Rajkumar, Vincent, Caples, Sean
Publicado 2010

Cytotoxic T-lymphocyte infiltration and chemokine predict long-term patient survival independently of tumor mutational burden in triple-negative breast cancer

por Katsuta, Eriko, Yan, Li, Opyrchal, Mateusz, Kalinski, Pawel, Takabe, Kazuaki
Publicado 2021

Primary and secondary breast angiosarcoma: single center report and a meta-analysis

por Abdou, Yara, Elkhanany, Ahmed, Attwood, Kristopher, Ji, Wenyan, Takabe, Kazuaki, Opyrchal, Mateusz
Publicado 2019

A Case of Metaplastic Breast Cancer with Prolonged Response to Single Agent Liposomal Doxorubicin

por Hamad, Lamya, Khoury, Thaer, Vona, Karen, Nestico, Jill, Opyrchal, Mateusz, Salerno, Kilian E
Publicado 2016

Exceptional Clinical Response to BRAF-Targeted Therapy in a Patient with Metastatic Sarcoma

por Mitsis, Demytra, Opyrchal, Mateusz, Zhao, Yujie, Kane III, John M, Cheney, Richard, Salerno, Kilian E
Publicado 2015

High MYC mRNA Expression Is More Clinically Relevant than MYC DNA Amplification in Triple-Negative Breast Cancer

por Katsuta, Eriko, Yan, Li, Takeshita, Takashi, McDonald, Kerry-Ann, Dasgupta, Subhamoy, Opyrchal, Mateusz, Takabe, Kazuaki
Publicado 2019

Contribution of Immune Cells to Glucocorticoid Receptor Expression in Breast Cancer

por Gandhi, Shipra, Elkhanany, Ahmed, Oshi, Masanori, Dai, Tao, Opyrchal, Mateusz, Mohammadpour, Hemn, Repasky, Elizabeth A., Takabe, Kazuaki
Publicado 2020

Systemic Therapy De-Escalation in Early-Stage Triple-Negative Breast Cancer: Dawn of a New Era?

por Gupta, Ravi Kumar, Roy, Arya Mariam, Gupta, Ashish, Takabe, Kazuaki, Dhakal, Ajay, Opyrchal, Mateusz, Kalinski, Pawel, Gandhi, Shipra
Publicado 2022

Oncolytic measles virus strains have significant antitumor activity against glioma stem cells

por Allen, Cory, Opyrchal, Mateusz, Aderca, Ileana, Schroeder, Mark A., Sarkaria, Jann N., Domingo, Evidio, Federspiel, Mark J., Galanis, Evanthia
Publicado 2012

Mechano-Sensing Channel PIEZO2 Enhances Invasive Phenotype in Triple-Negative Breast Cancer

por Katsuta, Eriko, Takabe, Kazuaki, Vujcic, Marija, Gottlieb, Philip A., Dai, Tao, Mercado-Perez, Arnaldo, Beyder, Arthur, Wang, Qingfei, Opyrchal, Mateusz
Publicado 2022

Phase I trial to evaluate the addition of alisertib to fulvestrant in women with endocrine-resistant, ER+ metastatic breast cancer

por Haddad, Tufia C., D’Assoro, Antonino, Suman, Vera, Opyrchal, Mateusz, Peethambaram, Prema, Liu, Minetta C., Goetz, Matthew P., Ingle, James N.
Publicado 2017

Recruitment of Intratumoral CD103(+) Dendritic Cells by a CXCR4 Antagonist-Armed Virotherapy Enhances Antitumor Immunity

por Mistarz, Anna, Komorowski, Marcin P., Graczyk, Matthew A., Gil, Margaret, Jiang, Aimin, Opyrchal, Mateusz, Rokita, Hanna, Odunsi, Kunle O., Kozbor, Danuta
Publicado 2019

Reprogramming antitumor immunity against chemoresistant ovarian cancer by a CXCR4 antagonist-armed viral oncotherapy

por Komorowski, Marcin P, McGray, AJ Robert, Kolakowska, Agnieszka, Eng, Kevin, Gil, Margaret, Opyrchal, Mateusz, Litwinska, Bogumila, Nemeth, Michael J, Odunsi, Kunle O, Kozbor, Danuta
Publicado 2016

A T Cell‐Engaging Tumor Organoid Platform for Pancreatic Cancer Immunotherapy

por Zhou, Zhuolong, Van der Jeught, Kevin, Li, Yujing, Sharma, Samantha, Yu, Tao, Moulana, Ishara, Liu, Sheng, Wan, Jun, Territo, Paul R., Opyrchal, Mateusz, Zhang, Xinna, Wan, Guohui, Lu, Xiongbin
Publicado 2023

Inhibition of Cdk2 kinase activity selectively targets the CD44(+)/CD24(−/Low) stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells...

por OPYRCHAL, MATEUSZ, SALISBURY, JEFFREY L., IANKOV, IANKO, GOETZ, MATHEW P., McCUBREY, JAMES, GAMBINO, MARIO W., MALATINO, LORENZO, PUCCIA, GIUSEPPE, INGLE, JAMES N., GALANIS, EVANTHIA, D’ASSORO, ANTONINO B.
Publicado 2014

Targeting PIM2 by JP11646 results in significant antitumor effects in solid tumors

por Katsuta, Eriko, Gil-Moore, Malgorzata, Moore, Justine, Yousif, Mohamed, Adjei, Alex A., Ding, Yi, Caserta, Justin, Baldino, Carmen M., Lee, Kelvin P., Gelman, Irwin H., Takabe, Kazuaki, Opyrchal, Mateusz
Publicado 2022

Outcome of Everolimus-Based Therapy in Hormone-Receptor-Positive Metastatic Breast Cancer Patients After Progression on Palbociclib

por Dhakal, Ajay, Antony Thomas, Roby, Levine, Ellis G, Brufsky, Adam, Takabe, Kazuaki, Hanna, Matthew G, Attwood, Kristopher, Miller, Austin, Khoury, Thaer, Early, Amy P, Soniwala, Saif, O’Connor, Tracy, Opyrchal, Mateusz
Publicado 2020